Your browser doesn't support javascript.
loading
Supraventricular Tachycardia in Pregnancy: Gestational and Labor Differences in Treatment.
Ibetoh, Crystal N; Stratulat, Eugeniu; Liu, Fan; Wuni, George Y; Bahuva, Ronak; Shafiq, Muhammad A; Gattas, Boula S; Gordon, Domonick K.
Afiliación
  • Ibetoh CN; Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Stratulat E; Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Liu F; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Wuni GY; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Bahuva R; Internal Medicine, California Institute of Behavioral Neuroscience & Psychology, Fairfield, USA.
  • Shafiq MA; Internal Medicine, University at Buffalo, Buffalo, USA.
  • Gattas BS; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
  • Gordon DK; Internal Medicine, Rawalpindi Medical University, Islamabad, PAK.
Cureus ; 13(10): e18479, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34659918
Supraventricular tachycardia (SVT) is a tachyarrhythmia characterized by a heart rate above 120 beats per minute (BPM). Patients with SVT exhibit the following symptoms: palpitations, shortness of breath, chest pain, hemodynamic instability, or possibly asymptomatic. The increase in cardiac output and the increase in resting heart rate during pregnancy predispose pregnant women to SVT. The management of SVT in pregnancy, although remarkably similar, varies slightly based on the trimester of pregnancy. Atenolol and verapamil are effective methods of treating SVT, which can be used during the second and third trimesters. Both medications are contraindicated in the first trimester. At the same time, intravenous adenosine can be used in all three trimesters, including labor. Electrical cardioversion is an effective treatment method for hemodynamically unstable or drug-refractory patients, which has proven to be safe in all three trimesters, including labor but can result in pre-term labor in the third trimester. Non-fluoroscopic ablation proved to be the only treatment method that definitively resolved SVT without recurrence.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos